Nymox Pharmaceutical Corporation (NYMXF)

OTCMKTS · Delayed Price · Currency is USD

0.1095

+0.0390 (55.32%)

At close: Mar 26, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Research and Development of Products for The Aging Population					5.00K	116.00K	299.00K	224.00K	284.00K
Research and Development of Products for The Aging Population Growth					-95.69%	-61.20%	33.48%	-21.13%	-89.72%
Total					5.00K	116.00K	299.00K	224.00K	284.00K
Total Growth					-95.69%	-61.20%	33.48%	-21.13%	-89.72%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Canada					-	1,000.00	1,000.00	5.00K	-
Canada Growth					-	0%	-80.00%	-	-
United States					3.00K	90.00K	276.00K	197.00K	232.00K
United States Growth					-96.67%	-67.39%	40.10%	-15.09%	4.50%
Europe					2.00K	24.00K	22.00K	21.00K	51.00K
Europe Growth					-91.67%	9.09%	4.76%	-58.82%	-97.98%
Total					5.00K	115.00K	299.00K	223.00K	283.00K
Total Growth					-95.65%	-61.54%	34.08%	-21.20%	-89.75%

Source: S&P Global Market Intelligence.